905 related articles for article (PubMed ID: 17251477)
21. The Candida albicans Ddr48 protein is essential for filamentation, stress response, and confers partial antifungal drug resistance.
Dib L; Hayek P; Sadek H; Beyrouthy B; Khalaf RA
Med Sci Monit; 2008 Jun; 14(6):BR113-121. PubMed ID: 18509269
[TBL] [Abstract][Full Text] [Related]
22. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis.
Park H; Myers CL; Sheppard DC; Phan QT; Sanchez AA; E Edwards J; Filler SG
Cell Microbiol; 2005 Apr; 7(4):499-510. PubMed ID: 15760450
[TBL] [Abstract][Full Text] [Related]
23. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
[TBL] [Abstract][Full Text] [Related]
24. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
Zhang H; Chen H; Niu J; Wang Y; Xie L
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
[TBL] [Abstract][Full Text] [Related]
25. Role of extracellular phospholipase B of Candida albicans as a virulent factor in experimental keratomycosis.
Ma L; Xie L; Dong X; Shi W
Curr Eye Res; 2009 Sep; 34(9):761-8. PubMed ID: 19839869
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylinositol-dependent phospholipases C Plc2 and Plc3 of Candida albicans are dispensable for morphogenesis and host-pathogen interaction.
Knechtle P; Goyard S; Brachat S; Ibrahim-Granet O; d'Enfert C
Res Microbiol; 2005 Aug; 156(7):822-9. PubMed ID: 16040234
[TBL] [Abstract][Full Text] [Related]
27. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
Chamilos G; Lionakis MS; Lewis RE; Lopez-Ribot JL; Saville SP; Albert ND; Halder G; Kontoyiannis DP
J Infect Dis; 2006 Apr; 193(7):1014-22. PubMed ID: 16518764
[TBL] [Abstract][Full Text] [Related]
28. Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
Girgis DO; Sloop GD; Reed JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2064-70. PubMed ID: 15914624
[TBL] [Abstract][Full Text] [Related]
29. Specific inhibition of Candida albicans growth in vitro by antibodies from experimental Candida keratitis mice.
Zhang H; Jia C; Xi H; Li S; Yang L; Wang Y
Exp Eye Res; 2011 Jul; 93(1):50-8. PubMed ID: 21540028
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans.
Thewes S; Moran GP; Magee BB; Schaller M; Sullivan DJ; Hube B
BMC Microbiol; 2008 Oct; 8():187. PubMed ID: 18950481
[TBL] [Abstract][Full Text] [Related]
31. Potential role of macrophages in experimental keratomycosis.
Hu J; Wang Y; Xie L
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2087-94. PubMed ID: 19074808
[TBL] [Abstract][Full Text] [Related]
32. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea.
Dong X; Shi W; Zeng Q; Xie L
Curr Eye Res; 2005 Aug; 30(8):613-20. PubMed ID: 16109640
[TBL] [Abstract][Full Text] [Related]
33. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis.
De Bernardis F; Arancia S; Morelli L; Hube B; Sanglard D; Schäfer W; Cassone A
J Infect Dis; 1999 Jan; 179(1):201-8. PubMed ID: 9841840
[TBL] [Abstract][Full Text] [Related]
34. CRZ1, a target of the calcineurin pathway in Candida albicans.
Karababa M; Valentino E; Pardini G; Coste AT; Bille J; Sanglard D
Mol Microbiol; 2006 Mar; 59(5):1429-51. PubMed ID: 16468987
[TBL] [Abstract][Full Text] [Related]
35. [Expression of inflammatory cytokines in a mouse model of keratomycosis].
Yin HM; Zhong WX; Xie LX
Zhonghua Yan Ke Za Zhi; 2010 Sep; 46(9):821-8. PubMed ID: 21092562
[TBL] [Abstract][Full Text] [Related]
36. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.
Stokes C; Moran GP; Spiering MJ; Cole GT; Coleman DC; Sullivan DJ
Fungal Genet Biol; 2007 Sep; 44(9):920-31. PubMed ID: 17251042
[TBL] [Abstract][Full Text] [Related]
37. Dosage-dependent roles of the Cwt1 transcription factor for cell wall architecture, morphogenesis, drug sensitivity and virulence in Candida albicans.
Moreno I; Martinez-Esparza M; Laforet LC; Sentandreu R; Ernst JF; Valentin E
Yeast; 2010 Feb; 27(2):77-87. PubMed ID: 19908200
[TBL] [Abstract][Full Text] [Related]
38. Animal models of candidiasis.
Clancy CJ; Cheng S; Nguyen MH
Methods Mol Biol; 2009; 499():65-76. PubMed ID: 19152040
[TBL] [Abstract][Full Text] [Related]
39. Molecular screening of donor corneas for fungi before excision.
Kercher L; Wardwell SA; Wilhelmus KR; Mitchell BM
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2578-83. PubMed ID: 11581202
[TBL] [Abstract][Full Text] [Related]
40. Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.
Yang YL; Wang CW; Chen CT; Wang MH; Hsiao CF; Lo HJ
Mycol Res; 2009 Mar; 113(Pt 3):388-90. PubMed ID: 19111931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]